FERTILITY PROFILE (LH,FSH,PRL,TSH)

The Fertility Profile is a blood-test panel that measures Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH), prolactin (PRL) and Thyroid-Stimulating Hormone (TSH). These hormones provide information about pituitary, ovarian, testicular and thyroid function. Their coordinated activity is important for menstrual-cycle regulation, ovulation, sperm production and reproductive health.

FSH and LH are produced by the pituitary gland and act on the ovaries in females and testes in males. Prolactin is another pituitary hormone that supports breast development and milk production but may interfere with reproductive function when persistently elevated outside pregnancy or breastfeeding. TSH regulates the thyroid gland, and thyroid dysfunction may affect menstrual regularity, ovulation, sexual function and fertility.

This panel can identify selected hormonal factors associated with fertility difficulties, but it cannot provide a complete fertility diagnosis by itself. It does not include AMH for ovarian-reserve assessment, estradiol, progesterone or testosterone. It also cannot evaluate egg quality, fallopian-tube patency, uterine structure or sperm concentration and motility. Results must be interpreted with symptoms, medical history, menstrual-cycle timing and other appropriate investigations.

Benefits of the Test

• Measures four important reproductive and endocrine hormones.
• Supports evaluation of ovarian, testicular and pituitary hormone signalling.
• Helps investigate irregular or absent menstrual periods.
• May support assessment of suspected ovulatory dysfunction.
• Assesses prolactin-related factors that may interfere with fertility.
• Checks TSH for thyroid-related reproductive abnormalities.
• May contribute to the hormonal evaluation of male infertility.
• Provides multiple related hormone results from one blood collection.
• Helps doctors determine whether further fertility or endocrine tests are required.

Why Doctors Recommend This Test

A doctor may recommend this Fertility Profile when a woman is experiencing difficulty becoming pregnant, irregular periods, absent periods or symptoms suggesting altered reproductive hormone function. The test may also be requested when ovulatory dysfunction, pituitary disease, abnormal prolactin or thyroid dysfunction is suspected.

In females, FSH promotes the growth and development of ovarian follicles. LH contributes to final follicle maturation and helps trigger ovulation. Concentrations of both hormones change throughout the menstrual cycle. Their results must therefore be assessed according to the menstrual-cycle phase and the clinical reason for testing.

In males, FSH supports sperm production, while LH stimulates cells in the testes to produce testosterone. Abnormal FSH or LH results may help doctors determine whether a hormonal problem originates primarily in the testes or in the pituitary or hypothalamus. However, this profile does not include testosterone and cannot directly assess sperm health.

Prolactin may be measured when a patient has infertility, irregular or absent periods, unexpected breast-milk production, reduced sexual desire or erectile difficulties. Persistently elevated prolactin may suppress the normal reproductive-hormone pathway. Pregnancy, breastfeeding, hypothyroidism, medicines and pituitary conditions are among the possible causes.

TSH testing helps assess thyroid function. An underactive or overactive thyroid may affect menstrual cycles, ovulation, sexual function and reproductive health. An abnormal TSH result does not identify the complete cause by itself. Free T4, thyroid antibodies and other tests may be required.

The profile may also be used when symptoms suggest a broader pituitary disorder. Because the pituitary gland produces FSH, LH, prolactin and TSH, abnormal patterns involving several hormones may indicate the need for specialist assessment and additional pituitary investigations.

Preparation Before Test

A blood sample is collected from a vein in the arm. Fasting is not always required solely for LH, FSH, prolactin and TSH testing. However, morning collection or fasting may be recommended depending on the clinical purpose and other tests ordered simultaneously. Follow the instructions provided by the doctor or Focus Diagnostics.

Female patients should inform the doctor and laboratory about the first day of their last menstrual period and usual cycle length. FSH and LH change during the menstrual cycle. For baseline reproductive assessment, a doctor may request testing during the early follicular phase, commonly around cycle days 2 to 5.

Prolactin changes during the day and may rise temporarily because of sleep, emotional stress, pain, strenuous exercise, sexual activity or nipple stimulation. A doctor may recommend morning collection a few hours after waking. Resting quietly for approximately 20 to 30 minutes before collection may help limit stress-related elevation when instructed.

Inform the doctor about pregnancy or breastfeeding because prolactin normally increases in these situations. Also report irregular periods, thyroid disease, pituitary disease, recent illness, fertility treatment and any previous abnormal hormone results.

Provide a complete list of prescribed medicines, non-prescription medicines, vitamins and supplements. Fertility medicines, hormonal contraceptives, thyroid medicines, antipsychotics, antidepressants, anti-nausea medicines, estrogen, testosterone and several other treatments may affect one or more results. Biotin supplements may interfere with some laboratory immunoassays.

Do not stop or change any prescribed medicine without instructions from the treating doctor. If an unexpected prolactin or thyroid result is identified, the doctor may advise repeat testing under standardised conditions before making a diagnosis.

Normal Reporting Time

The Fertility Profile is generally reported on the same day or within 24 hours after the laboratory receives an acceptable blood sample. The exact turnaround time may vary according to collection time, laboratory workload and the testing schedule for all four hormones.

Reporting may take longer when a result requires repeat analysis, dilution, quality verification or confirmation using another sample. Patients who require the report before a fertility appointment or treatment cycle should confirm the expected turnaround time with the collection centre.

Who Should Take This Test?

This panel may be appropriate for women who have difficulty becoming pregnant, irregular menstrual periods, absent periods or suspected ovulatory dysfunction. It may also be advised for women with unexpected breast discharge, reduced sexual interest or symptoms that suggest thyroid dysfunction.

Men undergoing infertility evaluation may require FSH, LH and prolactin testing when a hormonal cause is suspected. Symptoms such as low sexual desire, erectile difficulties, reduced body hair, loss of muscle mass or an abnormal semen analysis may lead a doctor to request reproductive hormone tests. Total testosterone and other investigations are often required in addition to this panel.

Patients with possible pituitary disorders may also require these hormones. Symptoms can include persistent headaches, vision changes, unexpected breast-milk production, menstrual changes or sexual dysfunction. Such symptoms require medical assessment and should not be evaluated using laboratory results alone.

The test may be considered for people with possible thyroid-related fertility problems, particularly when menstrual changes occur with tiredness, unexplained weight change, altered temperature tolerance, constipation, palpitations or other thyroid symptoms.

This profile is not a general guarantee of fertility and is not required for every person. The doctor should select tests according to the patient's sex, symptoms, reproductive history and intended clinical decision.

Understanding the Hormones

Luteinizing Hormone: In females, LH contributes to ovarian hormone production and triggers ovulation through a mid-cycle surge. In males, it stimulates testosterone production in the testes. Increased or decreased values may occur with ovarian or testicular dysfunction, PCOS, menopause, or pituitary and hypothalamic disorders.

Follicle-Stimulating Hormone: In females, FSH stimulates ovarian follicles to grow. An increased early-cycle result may be associated with reduced ovarian response or ovarian insufficiency. In males, FSH supports sperm production, and an elevated result may be associated with impaired testicular sperm-producing function.

Prolactin: Prolactin supports milk production after childbirth. When persistently elevated outside pregnancy or breastfeeding, it may interfere with reproductive hormone signalling. Causes may include certain medicines, hypothyroidism, pituitary conditions, kidney or liver disease, and temporary physiological factors. A mildly elevated result often requires repeat testing.

Thyroid-Stimulating Hormone: TSH is produced by the pituitary gland and instructs the thyroid to produce thyroid hormones. An increased TSH commonly suggests underactive thyroid function, while a decreased result may occur with overactive thyroid function or other conditions. TSH must often be interpreted with free T4.

Detailed Information

Reproductive function depends on coordinated communication between the hypothalamus, pituitary gland, ovaries or testes and the thyroid gland. The hypothalamus signals the pituitary gland, which releases FSH and LH. These hormones act on the reproductive organs and support egg development, ovulation, sperm production and sex-hormone production.

Doctors interpret FSH and LH as a pattern rather than relying on either result alone. Increased FSH and LH may indicate reduced response from the ovaries or testes, while low or inappropriately normal values may suggest insufficient stimulation from the hypothalamus or pituitary gland. The clinical meaning differs according to sex, age and reproductive status.

In females, LH and FSH results are affected by menstrual-cycle timing. Values considered expected during the early follicular phase may not be expected during the ovulatory or luteal phase. Menopause also produces a different hormone pattern. The exact cycle day should therefore be recorded when relevant.

Prolactin results require careful interpretation because temporary elevations are common. A high result may be repeated after adequate rest. Depending on the concentration and symptoms, the doctor may investigate pregnancy, thyroid function, medicines, macroprolactin or pituitary conditions.

TSH interpretation may differ during pregnancy or fertility-treatment planning from general adult interpretation. A result outside the appropriate clinical target may require free T4, thyroid antibodies or repeat testing. Patients should not change thyroid medicine without medical advice.

A normal Fertility Profile does not exclude infertility. Female evaluation may additionally require AMH, estradiol, progesterone, pelvic ultrasound, ovulation assessment, tubal-patency testing and examination of the uterus. Male evaluation commonly requires semen analysis and testosterone measurement.

Reference intervals vary according to sex, age, menstrual-cycle phase, pregnancy status, medicines and laboratory method. Patients should use the ranges printed on their Focus Diagnostics report. An abnormal result does not automatically indicate permanent infertility, and treatment should not be started or changed without professional interpretation.